Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest versus GnRH agonist after laparoscopic surgery for endometriosis-related infertility
IRCT20091012002576N40Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dienogest in endometriosis and female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Take home baby. Started Apr 2024; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosisfemale infertility
Beyond the preview
Go deeper on IRCT20091012002576N40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N40.